E3 PreliminaryPreliminaryPEM unclearReview-NarrativePeer-reviewedReviewed
Do vasoactive neuropeptides and heat shock proteins mediate fatigue-related autoimmune disorders?
Staines, Donald R · Medical hypotheses · 2005 · DOI
Quick Summary
This paper proposes that ME/CFS and similar fatigue disorders may be caused by the immune system attacking special messenger molecules in the body called vasoactive neuropeptides. These molecules normally help control energy metabolism, nerve function, and immune responses. The authors suggest that when antibodies damage these molecules, it could explain the severe fatigue and other symptoms seen in ME/CFS.
Why It Matters
This hypothesis identifies vasoactive neuropeptides and their interactions with heat shock proteins as potential therapeutic targets for ME/CFS research. If validated, it could explain both the neurological and metabolic dysfunction observed in ME/CFS and suggest new diagnostic biomarkers and treatment strategies.
Observed Findings
- No empirical data presented; this is a theoretical hypothesis paper.
- Autoimmune dysfunction of vasoactive neuropeptides is theoretically proposed as a mechanism in fatigue-associated disorders.
- Vasoactive neuropeptides are known to regulate metabolism, neurotransmission, and immune function.
- Vasoactive neuropeptides associate with heat shock proteins for intracellular function.
Inferred Conclusions
- Vasoactive neuropeptides represent a vulnerable target for autoimmune dysfunction due to their critical roles in cellular processes.
- Vasoactive neuropeptide-heat shock protein complexes warrant investigation as potential immunostimulating factors in fatigue disorders.
- Loss or compromise of vasoactive neuropeptide function would produce predictable cellular and systemic pathology consistent with ME/CFS symptoms.
Remaining Questions
- Do ME/CFS patients demonstrate antibodies against vasoactive neuropeptides compared to healthy controls?
- What is the prevalence and specificity of VN-directed autoimmunity in different fatigue-associated disorders?
- Do vasoactive neuropeptide-heat shock protein complexes stimulate pathogenic immune responses in affected patients?
What This Study Does Not Prove
This is a hypothesis paper, not an empirical study—it presents theoretical arguments without experimental data, patient samples, or clinical evidence. It does not establish that VN autoimmunity actually occurs in ME/CFS patients or that HSP-VN complexes cause fatigue symptoms. The proposal remains speculative and requires rigorous testing in clinical and laboratory studies.
Tags
Symptom:Fatigue
Biomarker:AutoantibodiesBlood Biomarker
Method Flag:Exploratory OnlyPEM Not Defined
Metadata
- DOI
- 10.1016/j.mehy.2004.08.013
- PMID
- 15617862
- Review status
- Editor reviewed
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 12 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.